In colorectal cancer (CRC), ARHGAP30 levels correlate with p53 acetylation and functional activation (Wang et al. 2014), and ARHGAP30 has been proposed as a prognostic marker for CRC (Wang et al. 2014), early-stage pancreatic ductal adenocarcinoma (Liao et al. 2017) and lung adenocarcinoma (Li et al. 2018). This evidence concerns the gene ARHGAP30 and colorectal carcinoma.